RIL
STOK icon

Rothschild Investment LLC’s Stoke Therapeutics STOK Stock Holding History

Rothschild Investment LLC’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.47K Sell
291
-2
-0.7% -$66 ﹤0.01% 1709
2025
Q4 		$9.3K Buy
293
+3
+1% +$90 ﹤0.01% 1597
2025
Q3 		$6.82K Sell
290
-40
-12% -$685 ﹤0.01% 1586
2025
Q2 		$3.75K Buy
330
+305
+1,220% +$2.9K ﹤0.01% 1654
2025
Q1 		$166 Sell
25
-25
-50% -$233 ﹤0.01% 2888
2024
Q4 		$552 Buy
50
+10
+25% +$123 ﹤0.01% 2495
2024
Q3 		$492 Buy
40
+10
+33% +$142 ﹤0.01% 2469
2024
Q2 		$405 Buy
+30
New +$405 ﹤0.01% 2151

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Rothschild Investment LLC's STOK Position: Q1 2026 in Review

Rothschild Investment LLC reduced its Stoke Therapeutics (STOK) stake by 0.68% in Q1 2026, selling an estimated $66 and leaving 291 shares worth $9.47K. The position accounts for ﹤0.01% of the portfolio, ranked #1709.

Rothschild Investment LLC first reported a position in STOK in Q2 2024 and has held it in 8 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Rothschild Investment LLC held 291 shares of Stoke Therapeutics worth $9.47K as of Q1 2026.
  • Rothschild Investment LLC sold 2 Stoke Therapeutics shares in Q1 2026, an estimated $66.
  • Stoke Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #1709 holding.
  • Rothschild Investment LLC first reported a position in Stoke Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.